IRIS
MASTRANGELO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 132
NA - Nord America 94
AS - Asia 5
AF - Africa 2
SA - Sud America 1
Totale 234
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 92
SE - Svezia 76
IT - Italia 33
FI - Finlandia 10
DE - Germania 8
PH - Filippine 4
MD - Moldavia 3
CA - Canada 2
TN - Tunisia 2
BR - Brasile 1
IR - Iran 1
MK - Macedonia 1
NL - Olanda 1
Totale 234
Salva come PNG Salva come JPEG
Città #
Lawrence 16
Princeton 16
Washington 11
Helsinki 10
Vittoria 5
Quezon City 4
Angera 3
Borås 3
Chisinau 3
Milan 3
Segrate 2
Torre Del Greco 2
Verona 2
Amsterdam 1
Falkenstein 1
Huskvarna 1
Lainate 1
Mahestan 1
Montréal 1
Paliano 1
Pavia 1
Rome 1
San Sperate 1
Seelze 1
Skopje 1
Totale 92
Salva come PNG Salva come JPEG
Nome #
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 35
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 20
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 19
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 19
The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19 18
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 15
Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study) 15
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection 14
Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals 13
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 13
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients 13
VIRO-immunological outcomes after 13-valent pneumococcal vaccination in HIV-1-infected individuals on stable virological suppression 12
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients 12
Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes 12
HIV-DNA undetectability during chronic HIV infection: Frequency and predictive factors 11
Rhodococcus defluvii pneumonia: First reported case in humans 10
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 10
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice 7
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 2
Totale 270
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 4 0 10 0 3 1 0 1 0
2021/202243 0 0 0 6 0 6 4 6 4 3 2 12
2022/2023135 40 30 10 2 6 13 8 15 5 0 2 4
2023/202473 8 19 46 0 0 0 0 0 0 0 0 0
Totale 270